J SURG ONCOL 润色咨询

JOURNAL OF SURGICAL ONCOLOGY

出版年份:暂无数据 年文章数:5451 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2020-04-28 zhanyu

    同问hemeifeng2009 2018-10-06 00:00:00 发表:
    该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?

    hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2023-01-10 ms3000000907122076 来自广西

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肝癌
    经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2022-12-29 ms5000000029332336 来自辽宁省

    偏重的研究方向:肿瘤;癌症;预后
    经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2022-10-30 14735239m04暂无昵称

    请问这个杂志有选项可以不收版面费吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2022-10-30 小白先生

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:癌症;临床
    经验分享:#临床回顾性分析# 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2021-03-06 Black doctor

    请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2022-08-17 Doctor小雷

    偏重的研究方向:肝癌放射外科;预后;临床
    经验分享:有大佬分享这个期刊的投稿吗?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2021-08-18 ydz96

    想问一下为什么一提交就变成under review了呀

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2022-05-30 ms8000001841029529

    有没有人图片上传失败的啊,要怎么上传疯了要

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945958, encodeId=1874945958c6, content=请问这个稿一般多久啊,我一投过去状态就是under review,好几天了也没变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Sat Mar 06 15:24:56 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239287, encodeId=570e123928e61, content=偏重的研究方向:肝癌放射外科;预后;临床<br>经验分享:有大佬分享这个期刊的投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Wed Aug 17 15:00:51 CST 2022, time=2022-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008930, encodeId=0cdb100893021, content=想问一下为什么一提交就变成under review了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TlSoNOCicNTkibssYfrMtXUxcF2Pj0ia5XXWZPdrj3AfysPvPTOmGCAicmWg9T5SRcATicCsyDGwNrqR6XuY9OfPdyw/132, createdBy=4d702569013, createdName=ydz96, createdTime=Wed Aug 18 09:14:20 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223451, encodeId=e6b312234512d, content=有没有人图片上传失败的啊,要怎么上传疯了要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50e8174857, createdName=ms8000001841029529, createdTime=Mon May 30 21:33:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811842, encodeId=f37981184257, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/966a7f07a46b4bd483d153292f53b86c/3b8a1e3e295147959cca29afa54e78c9.jpg, createdBy=16d75204401, createdName=147471bbm22暂无昵称, createdTime=Fri Aug 21 16:20:29 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2020-08-21 147471bbm22暂无昵称

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:方向:妇科肿瘤 微创手术 3-3投稿,4-22一审返修,只有一个审稿人的意见,需要改的不多,逐条修改回复后6-1返稿,6-23接收,校稿后7-3online。可以说非常高效了,非常适合要毕业的学生。

    6

    展开6条回复
共112条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分